Literature DB >> 20223136

[Extracorporeal lithotripsy in children - the efficacy and long-term evaluation of renal parenchyma damage by DMSA-99mTc scintigraphy].

L O Reis1, E L Zani, O Ikari, A Gugliotta.   

Abstract

PURPOSE: To determine the effectiveness of extracorporeal shock-wave lithotripsy (ESWL) and possible deleterious effects on renal parenchyma of children subjected to treatment of renal lithiasis, using renal scintigraphy with 99mTc dimercapto-succunic acid (DMSA). PATIENTS AND METHODS: From January 2004 to November 2007, 18 children (age 3-10 years) underwent ESWL (Philips-Dornier) for kidney urolithiasis. All patients underwent preoperative evaluation, including physical examination, urine culture, image exams and renal scintigraphy with Tc99-DMSA. Evaluation after treatment consisted of a clinical examination, blood pressure measurement, urine culture, renal ultrasound and Tc99-DMSA, repeated at 3, 6 and 12 months, which were compared to the scans obtained before ESWL to determine possible morphological or functional changes.
RESULTS: Success in the stones fragmentation was achieved in all cases - in 9 patients (50%) with one session of ESWL, in 6 (33%) with two sessions and in 3 patients (17%) with 3 sessions of ESWL. Only one patient (5%), after three sessions of ESWL and 6 months of follow-up showed change in size of right kidney with a decrease in tubular function, without hypertension or other major changes. In the other cases, there was absence of hypertension up to 12 months of follow-up, absence of renal hematomas detected by ultrasound or significant renal scars in scintigraphic examinations.
CONCLUSION: ESWL is effective and safe for treating renal lithiasis in children. Renal parenchyma lesions may occur early after treatment, but these lesions are transients and resolve spontaneously in virtually all cases; generally, there are no irreversible renal lesions associated with ESWL, even after the follow-up period with clinical examination, ultrasound examination and 99mTc-DMSA scintigraphy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223136     DOI: 10.1016/s2173-5786(10)70013-5

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  6 in total

1.  Impact of stone removal on renal function: a review.

Authors:  Kyle Wood; Tristan Keys; Patrick Mufarrij; Dean G Assimos
Journal:  Rev Urol       Date:  2011

Review 2.  Stones in special situations.

Authors:  Mordechai Duvdevani; Stavros Sfoungaristos; Karim Bensalah; Benoit Peyronnet; Amy Krambeck; Sanjay Khadji; Ahmet Muslumanuglu; David Leavitt; Jude Divers; Zeph Okeke; Arthur Smith; Janelle Fox; Michael Ost; Andreas J Gross; Hassan Razvi
Journal:  World J Urol       Date:  2017-03-07       Impact factor: 4.226

3.  Shock wave lithotripsy or retrograde intrarenal surgery: which one is more effective for 10-20-mm renal stones in children.

Authors:  Giray Ergin; Mustafa Kirac; Burak Kopru; Turgay Ebiloglu; Yusuf Kibar; Hasan Biri
Journal:  Ir J Med Sci       Date:  2018-03-03       Impact factor: 1.568

4.  Extracorporeal Shock Wave Lithotripsy and Combined Therapy in Children: Efficacy and Long-Term Results.

Authors:  Laura Burgos Lucena; Beatriz Fernández Bautista; Alberto Parente Hernández; Ruben Ortiz Rodríguez; Jose María Angulo Madero
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

5.  Interleukin-18 and NGAL in assessment of ESWL treatment safety in children with urolithiasis.

Authors:  Katarzyna Jobs; Ewa Straż-Żebrowska; Małgorzata Placzyńska; Robert Zdanowski; Bolesław Kalicki; Sławomir Lewicki; Anna Jung
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

6.  Effects of previous unsuccessful extracorporeal shockwave lithotripsy treatment on the performance and outcome of percutaneous nephrolithotomy.

Authors:  Hakan Türk; Mehmet Yoldaş; Tufan Süelözgen; Cemal Selcuk İşoğlu; Mustafa Karabıçak; Batuhan Ergani; Sıtkı Ün
Journal:  Arab J Urol       Date:  2017-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.